Cited by 5COVID-19 Clinical Research StudiesStatistical Methods in EpidemiologySepsis Diagnosis and Treatment

Prognostic models for COVID-19 needed updating to warrant transportability over time and space

Open access
van Klaveren, David, Zanos, Theodoros P., Nelson, Jason, Levy, Todd J., Park, Jinny G., Retel Helmrich, Isabel R. A., Rietjens, Judith A. C., Basile, Melissa J. +3 more·2022·BMC Medicine

Abstract

Background: Supporting decisions for patients who present to the emergency department (ED) with COVID-19 requires accurate prognostication. We aimed to evaluate prognostic models for predicting outcomes in hospitalized patients with COVID-19, in different locations and across time. Methods: We included patients who presented to the ED with suspected COVID-19 and were admitted to 12 hospitals in the New York City (NYC) area and 4 large Dutch hospitals. We used second-wave patients who presented between September and December 2020 (2137 and 3252 in NYC and the Netherlands, respectively) to evaluate models that were developed on first-wave patients who presented between March and August 2020 (12,163 and 5831). We evaluated two prognostic models for in-hospital death: The Northwell COVID-19 Survival (NOCOS) model was developed on NYC data and the COVID Outcome Prediction in the Emergency Department (COPE) model was developed on Dutch data. These models were validated on subsequent second-wave data at the same site (temporal validation) and at the other site (geographic validation). We assessed model performance by the Area Under the receiver operating characteristic Curve (AUC), by the E-statistic, and by net benefit. Results: Twenty-eight-day mortality was considerably higher in the NYC first-wave data (21.0%), compared to the second-wave (10.1%) and the Dutch data (first wave 10.8%; second wave 10.0%). COPE discriminated well at temporal validation (AUC 0.82), with excellent calibration (E-statistic 0.8%). At geographic validation, discrimination was satisfactory (AUC 0.78), but with moderate over-prediction of mortality risk, particularly in higher-risk patients (E-statistic 2.9%). While discrimination was adequate when NOCOS was tested on second-wave NYC data (AUC 0.77), NOCOS systematically overestimated the mortality risk (E-statistic 5.1%). Discrimination in the Dutch data was good (AUC 0.81), but with over-prediction of risk, particularly in lower-risk patients (E-statistic 4.0%). Recalibration of COPE and NOCOS led to limited net benefit improvement in Dutch data, but to substantial net benefit improvement in NYC data. Conclusions: NOCOS performed moderately worse than COPE, probably reflecting unique aspects of the early pandemic in NYC. Frequent updating of prognostic models is likely to be required for transportability over time and space during a dynamic pandemic.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12916-022-02651-3

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 34 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [28]Gulati G, Upshaw JN, Wessler BS, Brazil RJ, Nelson J, van Klaveren D, et al. The Generalizability of Cardiovascular Disease Clinical Prediction Models: 158 Large-Scale Independent External Validations of 104 Unique Models. Circ Cardiovasc Qual Outcomes. 2022;15(4):e008487. PMC9015037 35354282

Cited by

Sorted by citations

Authors
van Klaveren, D., Zanos, T. P., Nelson, J., Levy, T. J., Park, J. G., Retel Helmrich, I. R. A., Rietjens, J. A. C., Basile, M. J., Hajizadeh, N., Lingsma, H. F., & Kent, D. M.
Affiliations
  • Northwell Health (US)
  • Tufts Medical Center (US)
  • Erasmus MC (NL)
Venue
BMC Medicine
Published
2022-11-23
Volume
20
Issue
1
Pages
456-456
ISSN
1741-7015 (ISSN-L)
OpenAlex
W4309890846
Cited by
5
References
34
Citations by year
2026: 2 · 2024: 2 · 2023: 1
FWCI
0.37
Type
journal article
Language
en
Open access
Locations
  • BMC Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, cc-by)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Patient-Centered Outcomes Research Institute (ME-1606-35555)
  • ZonMw (10430 01 201 0019)
Topics
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
  • Health Sciences › Medicine › Epidemiology › Sepsis Diagnosis and Treatment
Keywords
COVID-19 pandemic, prognostic model, in-hospital mortality prediction, model portability, temporal validation, model recalibration, second wave of COVID-19, emergency department, model updating, New York City, Netherlands, net benefit, discrimination and calibration, hospitalized patients
MeSH terms
COVID-19, Humans, New York City, Prognosis, ROC Curve, Hospital Mortality

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review